These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 23130818)
1. Mortality in members of HIV-1 serodiscordant couples in Africa and implications for antiretroviral therapy initiation: results of analyses from a multicenter randomized trial. de Bruyn G; Magaret A; Baeten JM; Lingappa JR; Ndase P; Celum C; Wald A; BMC Infect Dis; 2012 Oct; 12():277. PubMed ID: 23130818 [TBL] [Abstract][Full Text] [Related]
2. Antiretroviral Therapy to Prevent HIV Acquisition in Serodiscordant Couples in a Hyperendemic Community in Rural South Africa. Oldenburg CE; Bärnighausen T; Tanser F; Iwuji CC; De Gruttola V; Seage GR; Mimiaga MJ; Mayer KH; Pillay D; Harling G Clin Infect Dis; 2016 Aug; 63(4):548-54. PubMed ID: 27208044 [TBL] [Abstract][Full Text] [Related]
3. Delay of antiretroviral therapy initiation is common in East African HIV-infected individuals in serodiscordant partnerships. Mujugira A; Celum C; Thomas KK; Farquhar C; Mugo N; Katabira E; Bukusi EA; Tumwesigye E; Baeten JM; J Acquir Immune Defic Syndr; 2014 Aug; 66(4):436-42. PubMed ID: 24798765 [TBL] [Abstract][Full Text] [Related]
4. Younger Age Predicts Failure to Achieve Viral Suppression and Virologic Rebound Among HIV-1-Infected Persons in Serodiscordant Partnerships. Mujugira A; Celum C; Tappero JW; Ronald A; Mugo N; Baeten JM AIDS Res Hum Retroviruses; 2016 Feb; 32(2):148-54. PubMed ID: 26670218 [TBL] [Abstract][Full Text] [Related]
5. Mortality, AIDS-morbidity, and loss to follow-up by current CD4 cell count among HIV-1-infected adults receiving antiretroviral therapy in Africa and Asia: data from the ANRS 12222 collaboration. Gabillard D; Lewden C; Ndoye I; Moh R; Segeral O; Tonwe-Gold B; Etard JF; Pagnaroat M; Fournier-Nicolle I; Eholié S; Konate I; Minga A; Mpoudi-Ngole E; Koulla-Shiro S; Zannou DM; Anglaret X; Laurent C; J Acquir Immune Defic Syndr; 2013 Apr; 62(5):555-61. PubMed ID: 23274931 [TBL] [Abstract][Full Text] [Related]
6. Optimal uses of antiretrovirals for prevention in HIV-1 serodiscordant heterosexual couples in South Africa: a modelling study. Hallett TB; Baeten JM; Heffron R; Barnabas R; de Bruyn G; Cremin Í; Delany S; Garnett GP; Gray G; Johnson L; McIntyre J; Rees H; Celum C PLoS Med; 2011 Nov; 8(11):e1001123. PubMed ID: 22110407 [TBL] [Abstract][Full Text] [Related]
7. Gender differences in survival among adult patients starting antiretroviral therapy in South Africa: a multicentre cohort study. Cornell M; Schomaker M; Garone DB; Giddy J; Hoffmann CJ; Lessells R; Maskew M; Prozesky H; Wood R; Johnson LF; Egger M; Boulle A; Myer L; PLoS Med; 2012; 9(9):e1001304. PubMed ID: 22973181 [TBL] [Abstract][Full Text] [Related]
9. Characteristics of HIV-1 discordant couples enrolled in a trial of HSV-2 suppression to reduce HIV-1 transmission: the partners study. Lingappa JR; Kahle E; Mugo N; Mujugira A; Magaret A; Baeten J; Bukusi EA; Cohen CR; Katabira E; Ronald A; Kiarie J; Farquhar C; Stewart GJ; Makhema J; Essex M; Were E; Fife K; Debruyn G; Gray G; McIntyre J; Manongi R; Kapiga S; Coetzee D; Allen S; Inambao M; Kayitenkore K; Karita E; Kanweka W; Delany S; Rees H; Vwalika B; Coombs RW; Morrow R; Whittington W; Corey L; Wald A; Celum C; PLoS One; 2009; 4(4):e5272. PubMed ID: 19404392 [TBL] [Abstract][Full Text] [Related]
10. Survival benefit of initiating antiretroviral therapy in HIV-infected persons in different CD4+ cell strata. Palella FJ; Deloria-Knoll M; Chmiel JS; Moorman AC; Wood KC; Greenberg AE; Holmberg SD; Ann Intern Med; 2003 Apr; 138(8):620-6. PubMed ID: 12693883 [TBL] [Abstract][Full Text] [Related]
11. Could early antiretroviral therapy entail more risks than benefits in sub-Saharan African HIV-infected adults? A model-based analysis. Anglaret X; Scott CA; Walensky RP; Ouattara E; Losina E; Moh R; Becker JE; Uhler L; Danel C; Messou E; Eholié S; Freedberg KA Antivir Ther; 2013; 18(1):45-55. PubMed ID: 22809695 [TBL] [Abstract][Full Text] [Related]
12. When to start antiretroviral therapy in resource-limited settings. Walensky RP; Wolf LL; Wood R; Fofana MO; Freedberg KA; Martinson NA; Paltiel AD; Anglaret X; Weinstein MC; Losina E; Ann Intern Med; 2009 Aug; 151(3):157-66. PubMed ID: 19620143 [TBL] [Abstract][Full Text] [Related]
13. High Transmitter CD4+ T-Cell Count Shortly after the Time of Transmission in a Study of African Serodiscordant Couples. Karita E; Price MA; Lakhi S; Kilembe W; Kamali A; Ruzagira E; Hunter E; Farmer P; Allen S; Stevens G; Chetty P; Welsh S; Yang A; Gilmour J; Fast P; PLoS One; 2015; 10(8):e0134438. PubMed ID: 26291456 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of Antiretroviral Therapy Initiated One Week after Tuberculosis Therapy in Patients with CD4 Counts < 200 Cells/μL: TB-HAART Study, a Randomized Clinical Trial. Amogne W; Aderaye G; Habtewold A; Yimer G; Makonnen E; Worku A; Sonnerborg A; Aklillu E; Lindquist L PLoS One; 2015; 10(5):e0122587. PubMed ID: 25966339 [TBL] [Abstract][Full Text] [Related]
15. Factors Associated with Timing of Initiation of Antiretroviral Therapy among HIV-1 Infected Adults in the Niger Delta Region of Nigeria. Ogoina D; Finomo F; Harry T; Inatimi O; Ebuenyi I; Tariladei WW; Afolayan AA PLoS One; 2015; 10(5):e0125665. PubMed ID: 25933356 [TBL] [Abstract][Full Text] [Related]
16. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)]. Panel de expertos de Gesida y Plan Nacional sobre el Sida Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764 [TBL] [Abstract][Full Text] [Related]
17. Mortality and its predictors among antiretroviral therapy naïve HIV-infected individuals with CD4 cell count ≥350 cells/mm(3) compared to the general population: data from a population-based prospective HIV cohort in Uganda. Masiira B; Baisley K; Mayanja BN; Kazooba P; Maher D; Kaleebu P Glob Health Action; 2014; 7():21843. PubMed ID: 24433941 [TBL] [Abstract][Full Text] [Related]
18. Early mortality after late initiation of antiretroviral therapy in the TREAT Asia HIV Observational Database (TAHOD) of the International Epidemiologic Databases to Evaluate AIDS (IeDEA) Asia-Pacific. Rupasinghe D; Kiertiburanakul S; Kamarulzaman A; Zhang F; Kumarasamy N; Chaiwarith R; Merati TP; Do CD; Khusuwan S; Avihingsanon A; Lee MP; Ly PS; Yunihastuti E; Nguyen KV; Ditangco R; Chan YJ; Pujari S; Ng OT; Choi JY; Sim B; Tanuma J; Sangle S; Ross J; Law M HIV Med; 2020 Jul; 21(6):397-402. PubMed ID: 31852025 [TBL] [Abstract][Full Text] [Related]
19. Suboptimal immune recovery during antiretroviral therapy with sustained HIV suppression in sub-Saharan Africa. Kroeze S; Ondoa P; Kityo CM; Siwale M; Akanmu S; Wellington M; de Jager M; Ive P; Mandaliya K; Stevens W; Boender TS; de Pundert ME; Sigaloff KCE; Reiss P; Wit FWNM; Rinke de Wit TF; Hamers RL AIDS; 2018 May; 32(8):1043-1051. PubMed ID: 29547445 [TBL] [Abstract][Full Text] [Related]
20. Depression and ART Initiation Among HIV Serodiscordant Couples in Kenya and Uganda. Velloza J; Celum C; Haberer JE; Ngure K; Irungu E; Mugo N; Baeten JM; Heffron R; AIDS Behav; 2017 Aug; 21(8):2509-2518. PubMed ID: 28634661 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]